摘要
目的:总结1991年5月～2000年12月间71例食管癌患者行内翻拔脱术及其综合治疗的结果。方法:71例食管癌患者,中位年龄62岁。其中Ⅰ期40例,Ⅱa期26例,Ⅱb期4例,Ⅳ期1例,均采用食管内翻拔脱术治疗,接受术前辅助放疗4000cGy者9例,术后辅助放疗6000cGy者17例,术前新辅助化疗者5例。结果:术后1、3、5年的生存率为:Ⅰ期100.00%、91.43%、86.21%;Ⅱa期92.00%、83.33%、57.14%;Ⅱb期75.00%、50.00%、50.00%;Ⅳ期100.00%、0、0;全组71例患者1、3、5年总生存率分别为95.71%、86.89%、71.70%。并发症发生率为12.68%。结论:食管内翻拔脱术结合放、化疗将使不能耐受经胸或不需经胸手术的Ⅱa期及更早期的食管癌患者获益。
Objective：The aim of this study was to analyze the results and introduce the experiences of transhiatal esophagectomy in combined With different synthetic therapy, Methods：Seventy-one patients with esophageal cancacinoma, median age was 62, 40 of stage Ⅰ ,26 of Ⅱ a,4 of stage Ⅱ b,1 of stage Ⅳ, were treated with transhiatal esophagectomy. 9 and 17 patients were treated with preoperative radiotherapy （4 000cGy） and postoperative adjuvant radiotherapy （6 000cGy ） respectively; 5 patients were treated with preoperative chemotherapy. Results：The postoperative 1,3 and 5 year survival rates were 100% ,91.43% ,86. 21% for stage Ⅰ ; 92% ,83.33% ,57. 14% for stage Iia;75% ,50% ,50% for stage Ⅱ b; 100% ,0,0 for stag Ⅳand 95.71% ,86. 89% ,71.70% as a whole. The incidence rate of complications was 12.68 %. Conclusion：Transhiatal esophagectomy combined with chemotherapy or radiotherapy may be beneficial to patients with esophageal carcinoma at stage Ⅱ a or earlier who can＇t tolerate or need not be treated by transthoracic esophagectomy.
出处
《临床肿瘤学杂志》
CAS
2007年第6期441-444,共4页
Chinese Clinical Oncology
关键词
食管肿瘤
食管内翻拔脱术
综合治疗
Esophageal carcinoma
Transhiatal esophagectomy
Synthetic therapy
